Rafael A. Irizarry
Dana-Farber Cancer Institute
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
CAR-T cell therapy research
Strong evidence · 1 supporting paper · latest 2024
Gut microbiota and health
Solid evidence · 3 supporting papers · latest 2026
Integrated Circuits and Semiconductor Failure Analysis
Solid evidence · 1 supporting paper · latest 2024
Molecular Biology Techniques and Applications
Solid evidence · 1 supporting paper · latest 2026
Genomics and Phylogenetic Studies
Solid evidence · 1 supporting paper · latest 2026
Environmental DNA in Biodiversity Studies
Solid evidence · 1 supporting paper · latest 2026
Cancer Research and Treatments
Solid evidence · 2 supporting papers · latest 2026
Cancer Genomics and Diagnostics
Solid evidence · 2 supporting papers · latest 2026
Publications (6)
Unique Molecular Identifiers Don’t Need to be Unique: A Collision-Aware Estimator for RNA-Seq Quantification
2026DOIPMID 42239132
Baseline immune state and T-cell clonal kinetics are associated with durable response to CAR-T therapy in large B-cell lymphoma
2024DOIPMID 39241199
Setting higher standards for reports of microbial species in human cancers
2026DOIPMID 41714823
Setting higher standards for reports of microbial species in human cancers.
2026DOI
An image-based transcriptomics atlas reveals the regional and microbiota-dependent molecular, cellular, and spatial structure of the murine gut
2026DOIPMID 41720094
A New Family of Poisson Non-negative Matrix Factorization Methods Using the Shifted Log Link
2026DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Dana-Farber Cancer Institute
Source: OpenAlex · retrieved 2026-09-29